Published 8 months ago

Telitacicept Shows Efficacy, Safety in Methotrexate-Resistant RA

Summary by mdedge.com

Telitacicept is a recombinant fusion protein that aims to target and neutralize B lymphocyte stimulator and a proliferation-inducing ligand (APRIL), both of which are linked to autoimmunity.

0 Articles

All

Left

Center

Right

mdedge.com

Telitacicept Shows Efficacy, Safety in Methotrexate-Resistant RA

Telitacicept is a recombinant fusion protein that aims to target and neutralize B lymphocyte stimulator and a proliferation-inducing ligand (APRIL), both of which are linked to autoimmunity.

8 months ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated8 months agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Telitacicept Shows Efficacy, Safety in Methotrexate-Resistant RA

0 Articles

0 Articles

Telitacicept Shows Efficacy, Safety in Methotrexate-Resistant RA

Telitacicept Shows Efficacy, Safety in Methotrexate-Resistant RA

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics